Exchange: NYSEMkt·Updated 07:56 PM EDT
KAPA logo

KAPA Kairos Pharma Ltd.

$0.53
$0.0101
(1.87%)
Today
Closed $0.53
$0.02
(3.77%)
After Hours
Mkt Cap$1.79M
Vol47,409.00

About KAPA

Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA.
40

Bearish Sentiment

How do you feel about KAPA?

NON_FICTION_1
$KAPA extremely low float, insanely low mc, super solid data, nice big pipeline, the only downside is this is a real company , shouldnt swing. Load and hold this for massive upside. This is not a shell or dead turd. We will see if they find it.
1
6
NON_FICTION_1
$KAPA .87 to 1.25 amazing gain just in a few hours. Huge volume. Should have went so much higher. Mms wanted it walked down. Always take massive profits when i hand them to you. Im watching this closely still … its so incredibly undervalued. But when you get a free 40-50% you have to lock it in. Watching for possible reload here very closely
7
Ijenkin08
$KAPA banging the table on mi at .90 went to $11S called sdev yesterday after hours at 3.28 sold 5.25 this morning. KAPA next
7
NON_FICTION_1
$KAPA Im sorry this should be $10+ min , if you want to call me a pumper thats fine. Ive only traded biotech for 2 decades what do i know. Sometimes they get lost or mispriced, and just need the valuation corrected.
6
Roaring_Capybara
$KAPA This mornings nosedive off the high scared a lot of people away. Thats exactly what is was intended to do. Where else are you going to find a stock with very exciting phase 2 cancer data ...... with a market cap of a few million dollars. This easily has $20 pps potential.
6
Roaring_Capybara
$KAPA Phase 2 pancreatic cancer - excellent data. At 52 week low. Ridiculously low $3.8M MC. I'm back in at 1.12
6
TheLastExit
$KAPA Actually, your posts are pure BS. I'm red but people like you make me sick...call ICE. What kind of inbred monkey take is that? Also, do your own research, Jack. There's more to the world wide web than Yahoo. Here's the CEO: John S. Yu (CEO & Chairman) 1985: BAS – Stanford University 1990: MD – Harvard Medical School 1990: Master’s Degree (Genetics) – Harvard University Residency at Massachusetts General till '97 and a professor at Cedars-Sinai since '98. Do you want to call the ICE on a US citizen that happens to be of asian descent? I could cary on, but I'm not wasting more oxygen on a racist dumbass.
1
1
TheLastExit
$KAPA there is no doubt that Kairos is in choppy waters, but what stupid and nefarious takes these are. Their address is a handled by a mail forwarding and mailbox service center, pretty normal with small companies to manage operations flexibly. The entire leadership team and board have spent their multi-decade professional and academic careers primarily inside the United States, with many tracking back to prestigious U.S. universities starting in the 1980s and 1990s. Most likely they're all US citizens. This poster is just a sore loser. Look, Buck. This is biotech. Things happen. If you can't handle it, invest in Vagisil.
1
1
Xtracked
$KAPA Got out before RS . .36c..this would be under a dime now. Was in last yr and spoke w this fk. He actually contacted me and influenced my decisions... which was criminal. His phone # if u don't believe 310 729 3371
4
Billypouli
$KAPA A huge that you to the noobs and weak, this is one of the best buys you can find here
1
1
JSP_Dilution_Player
$KAPA news looks good ..... 17 months vs 2 months.... just if they dropped when low floaters were hot ... oh well good luck
1
1
Stock_Catcher
$KAPA Kairos Pharma Reports Positive, Statistically Significant Interim Efficacy Data from Phase 2 Trial of ENV-105 in Metastatic Prostate Cancer
4
TraderBuckNKY
$KAPA I've been here for 2+ years...the recent history of this one is a spike with volume and then a drop/dump way down low....check it out on a 20/20 chart...there has always been the "possibilities" but it has been a constant dissappointment...
3
YouVSYou
$KAPA Bounce off .85 inside a steep 30m downtrend needs .99 / 1.00 breakout / retest / hold to open 1.09 / 1.17 / 1.28 .90 is the first hold lose it watch .85
3
Roaring_Capybara
$KAPA OK. Done my complaining and back to the Facts: 1) Extremely good phase 2 interim PC data. 2) Other indications outside of PC. 3) Collaboration with Bayer. 4) Most importantly, a $3.1 Million market cap. I think the Quickie Mart at the end of the block has a higher market cap.
3
Gooch72
$KAPA A drop like that with that kind of volume was completely nonsensical on good news. I’m in, no brainer…
3
uptrend2025
$KAPA The important addition today os the reported comparison against apalutamide alone. Not merely a higher PFS estimate. 17.7 months vs 2 months progression free survival. HUGE
3
Scorpole
$KAPA If management doesn't accept whatever buyout offer—which hopefully will come along—they might as well file for Chapter 11.
2
ka1954
$KAPA why the fuck company did a reverse split? they had almost a year befor eit was required for nasdaq compliance? company idiots killed their own fucking stock
2
ka1954
$KAPA piece of crap stock. tomorrow a new all time low will come. today was just a pump and dump
2

Advertisement|Remove ads.